Skip to main content

Table 1 Clinical characteristics of Monoarticular and Oligoarticular JIA

From: Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study

  

MonoJIA No.118†

OligoJIA No. 229

p

Sex (F)

83 (70.3)

191 (83.4)

0.004

Age at onset (years)

6.1 (3.9)

4.7 (3.2)

0.002

Presence of BJH

73 (61.9)

106 (46.3)

0.006

Uveitis

17 (14.4)

78 (34.1)

0.000

ANA+

81 (68.6)

205 (89.5)

0.000

Therapy

IACS

107 (90.7)

218 (95.2)

0.102

AIDs

60 (50.8)

199 (86.9)

0.000

csDMARD

22 (18.6)

181 (79.9)

0.000

bDMARD

6 (5.1)

83 (36.2)

0.000

Long-term outcome

CR

97 (82.2)

101 (44.1)

0.000

CRM

15 (12.7)

97 (42.4)

AD

6 (5.1)

31 (13.5)

  1. † Data are number (% or standard deviation)
  2. Legend: AD, active disease; ANA, antinuclear antibodies; CR, clinical remission; CRM, clinical remission on medication; F, female; BJH, benign joint hypermobility; monoJIA, monoarticular juvenile idiopathic arthritis; oligoJIA, oligoarticular juvenile idiopathic arthritis; IACS intra-articular corticosteroids; AIDs anti-inflammatory drugs; csDMARD conventional synthetic disease-modifying anti-rheumatic drugs; bDMARD biological disease-modifying anti-rheumatic drugs